SANTA CLARA, Calif. , Aug.andnbsp;The United States (U.S.) next-generation sequencing (NGS) informatics market is witnessing double-digit growth, supported by the increasing demand from molecular diagnostics, biopharmaceutical, and academic institution customers. Pharmaceutical companies' strong focus on developing precision and personalized therapies, the launch of large-scale genome sequencing projects, and expected reimbursement and approval policy developments for NGS-based diagnostic tests will augment the requirement for NGS informatics solutions. Click here for more.
from Cellular News http://bit.ly/2gnlDfm
0 commentaires:
Enregistrer un commentaire